1)- M L Dale, M Mancini, A Stevens, B H Brumbach, A Prewitt, G Harker, C Silva-Batista, A Ragothaman, R L Folmer, J F Quinn, F B Horak. C-STIM: Protocol for a randomized, single-blind, crossover study of cerebellar repetitive transcranial magnetic stimulation (rTMS) for postural instability in people with progressive supranuclear palsy (PSP).Contemporary clinical trials communications. 2023, 35: 101165
3)- Karen I Fredriksen-Goldsen, Brittany R Jones, Charles Hoy-Ellis, Hyun-Jun Kim, Charles A Emlet, David La Fazia, Glenise McKenzie, Ryan Petros, Linda Teri. Aging with Pride: Innovations in Dementia Empowerment and Action (IDEA).Contemporary clinical trials communications. 2023, 35: 101169
4)- Emily Sammons, Louise Bowman, William Stevens, Georgina Buck, Karl Wallendszus, Imen Hammami, Sarah Parish, Jane Armitage, . ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration.Contemporary clinical trials communications. 2023, 35: 101184
5)- Lisa J Woodhouse, Alan A Montgomery, Stuart Pocock, Marilyn James, Anna Ranta, Philip M Bath, . Optimising the analysis of vascular prevention trials: Re-Assessment of the TARDIS trial, the first prevention trial to adopt an ordinal primary outcome measure.Contemporary clinical trials communications. 2023, 35: 101186
6)- Edward N Janoff, Sheldon T Brown, Ilana Belitskaya-Levy, Jeffrey L Curtis, Robert A Bonomo, Elliott K Miller, Alexa M Goldberg, Lisa Zehm, Ashlea Wills, Caitlin Hutchinson, Larry J Dumont, Theresa Gleason, Mei-Chiung Shih, . Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise.Contemporary clinical trials communications. 2023, 35: 101190
7)- Carl T Berdahl, Andrew J Henreid, Tara N Cohen, Bernice L Coleman, Edward G Seferian, Donna Leang, Sungjin Kim, Marcio A Diniz, Matthew Grissinger, Karen Kaiser, Sara McCleskey, Xi Zhu, Teryl K Nuckols. Comparing the Safety Action Feedback and Engagement (SAFE) Loop with an established incident reporting system: Study protocol for a pragmatic cluster randomized controlled trial.Contemporary clinical trials communications. 2023, 35: 101192
8)- Yosef Sokol, Sarah Andrusier, Sofie Glatt, Lisa Dixon, Josephine Ridley, Clayton H Brown, Yulia Landa, Shirley Glynn, Marianne Goodman. Feasibility and acceptability of continuous identity cognitive therapy as a recovery-oriented suicide treatment for Veterans: A study protocol.Contemporary clinical trials communications. 2023, 35: 101193
9)- Chaeryon Kang, Di Zhang, James Schuster, Jane Kogan, Cara Nikolajski, Charles F Reynolds. Bias-corrected and doubly robust inference for the three-level longitudinal cluster-randomized trials with missing continuous outcomes and small number of clusters: Simulation study and application to a study for adults with serious mental illnesses.Contemporary clinical trials communications. 2023, 35: 101194
10)- Gillian R Ulrich, Krista W Ranby, Evelinn Borrayo. Underserved head-and-neck and lung cancer patient characteristics are associated with caregiver participation in a clinical trial.Contemporary clinical trials communications. 2023, 35: 101195
11)- Pei Wang, Zheng Wang, Zhong-Xin Li, Si-Hui Ma, Yan Li, Huan Li, Chao Yang, Man Yu, Jiao Wang, Yan-Chen An, Min Li. Efficacy and safety of acupuncture on insomnia in maintenance hemodialysis patients: A randomized clinical trial protocol.Contemporary clinical trials communications. 2023, 35: 101196
12)- Jillian R Scheer, Kriti Behari, Aubriana A Schwarz, Cory J Cascalheira, Emily C Helminen, Sophia A Pirog, Virinca Jaipuriyar, Tami P Sullivan, Abigail W Batchelder, Skyler D Jackson. Expressive writing treatments to reduce PTSD symptom severity and negative alcohol-related outcomes among trauma-exposed sexual minority women and transgender/nonbinary people: Study protocol for a mixed-method pilot trial.Contemporary clinical trials communications. 2023, 35: 101197
13)- Una J Lee, Keith Xavier, Kevin Benson, Kimberly Burgess, Janet E Harris-Hicks, Robert Simon, Jeffrey G Proctor, Katie C Bittner, Kira Q Stolen, Chris P Irwin, Sarah J Offutt, Anne E Miller, Elizabeth M Michaud, Phillip C Falkner, J Chris Coetzee. Rationale and design of an implant procedure and pivotal study to evaluate safety and effectiveness of Medtronic's tibial neuromodulation device.Contemporary clinical trials communications. 2023, 35: 101198
14)- Amy E Krefman, Jody D Ciolino, Ann K Kan, Bruce Maki, Megan McHugh, Justin D Smith, Jennifer Bannon, Allison J Carroll, Patricia Bustamante, Carrie Frye, Brian Hitsman, Anya Day, Theresa L Walunas. Rationale and design for Healthy Hearts for Michigan (HH4M): A pragmatic single-arm hybrid effectiveness-implementation study.Contemporary clinical trials communications. 2023, 35: 101199
16)- Mona Soheilian Khorzoghi, Mohammad Rostami-Nejad, Abbas Yadegar, Hossein Dabiri, Azam Hadadi, Luis Rodrigo. Impact of probiotics on gut microbiota composition and clinical symptoms of coeliac disease patients following gluten-free diet.Contemporary clinical trials communications. 2023, 35: 101201
17)- Maria Roriz, João Brito, Filipe J Teixeira, Konstantinos Spyrou, Vitor Hugo Teixeira. Menthol mouth rinsing and performance in elite football referees in the heat: A study protocol for a randomized crossover trial.Contemporary clinical trials communications. 2023, 35: 101202
19)- Anabel de la Rosa-Gómez, Alejandrina Hernández Posadas, Pablo D Valencia, Lorena Alejandra Flores-Plata, Berenice Serrano Zárate, Alicia Ivet Flores Elvira, Alejandro Dominguez-Rodriguez, Mario Fabián Vázquez Sánchez, Edith González Santiago. Online transdiagnostic intervention for emotional, trauma- and stressor-related disorders in the Mexican population: A randomized pilot and feasibility trial.Contemporary clinical trials communications. 2023, 35: 101204
20)- Aleksander H Erga, Guido Alves, Albert F G Leentjens. Corrigendum to "The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease" [Contemp. Clinic. Trials Commun. 32 (2023) 101080].Contemporary clinical trials communications. 2023, 35: 101205